for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Company News

BRIEF-IntelGenx submits Montelukast VersaFilm(tm) clinical trial application with Health Canada

Nov 9 (Reuters) - IntelGenx Technologies Corp

* IntelGenx submits Montelukast VersaFilm(tm) clinical trial application with Health Canada

* IntelGenx - submitted CTA to Health Canada for approval to initiate its Phase 2a POC study with Montelukast in mild to moderate alzheimer’s disease Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up